Xenon Pharmaceuticals Inc. (XENE) Operating margin 2016–2025
Xenon Pharmaceuticals Inc. (XENE) operating margin by fiscal year — reported operating income divided by reported revenue.
-4974.3%FY2025 · since FY2016: -1376.4% → -4974.3%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -4974.3% | — |
| FY2022 | -1368.9% | -940.5 pp |
| FY2021 | -428.4% | -331.1 pp |
| FY2020 | -97.3% | +529.7 pp |
| FY2019 | -627.0% | — |
| FY2017 | -10474.3% | -9097.8 pp |
| FY2016 | -1376.4% | — |
Operating margin = reported operating income ÷ reported revenue for the same fiscal year. Operating-loss years show as a negative margin.
Source: SEC XBRL filings · For reference only · Not investment advice